Classical Tolerance Induction in Renal Transplantation — A Study of 11 Patients
Article Outline
Background
Transplantation biology has accumulated evidence of persistent mixed lymphohematopoietic chimerism (MLHC) after allogeneic hematopoietic stem cell (HSC) grafting, resulting in donor-specific tolerance to alloantigens in solid organ transplantation. We aimed to design a safe, non-toxic, non-myeloablative, high-dose allogeneic HSC transplantation (HSCT) protocol to achieve grafting with persistent low-level MLHC-associated, donor-specific tolerance across major histocompatibility complex barriers in our living related donor (LRD) renal allograft recipients.
Methods
HSC infusion into the portal, marrow and systemic circulation was performed in 11 LRD renal allograft recipients. All patients underwent a tolerance induction protocol (TIP), but two patients also had HSC infusion (n = 1) or donor renal tissue inoculation (n = 1) into the recipient thymus. All patients received low-dose immunosuppressive therapy for a mean of 1 year post-transplantation. Such therapy was discontinued for the following reasons: poor compliance; drug toxicity; and low-level chimerism, as tested across gendermismatched donors by a fluorescent in situ hybridization technique.
Results
All patients had prope tolerance with early, stable allograft function without any episodes of rejection, infection, or graft versus host disease. MLHC could be tested in seven patients, all of whom showed persistent MLHC (average 0.54%) in peripheral blood. All patients had stable allograft function for a mean of 32.6 months after the withdrawal of immunosuppressive therapy, and all had a normal clinical profile as tested by laboratory parameters.
Conclusion
Of 483 patients who underwent TIP using HSCT, weaning of immunosuppressive therapy was implemented in 165 (34.2%), and 11 patients developed successful MLHC-associated donor-specific tolerance.
Key words: donor-specific transplantation tolerance , hematopoietic stem cell transplantation , mixed lymphohematopoietic chimerism , renal transplantation , tolerance induction protocol
No full text is available. To read the body of this article, please view the PDF online.
References
- High dose DBMC associated tolerance in live-related renal allograft recipients . Transplant Proc . 2000;32:2001–2002
- Megadose approach to DBMC infusion-induced allograft hyporesponsiveness in living-related renal allograft recipients . Transplant Proc . 2001;33:71–76
- High-dose peripheral blood stem cell infusion: a strategy to induce donor-specific hyporesponsiveness to allografts in pediatric renal transplant recipients . Pediatr Transplant . 2002;6:63–68
- Mega dose unfractionated donor bone marrow-derived cell infusion in thymus and periphery - an integrated clinical approach for tolerance in living related renal allografts . Transplant Proc . 2003;35:203–206
- . 'Actively acquired tolerance' of foreign cells . Nature . 1953;172:603–606
- . Induction of kidney transplantation tolerance across major histocompatibility complex barriers by bone marrow transplantation in miniature swine . Transplantation . 1991;51:862–866
- Successful induction of long-term specific tolerance to fully allogeneic renal allografts in miniature swine . Transplantation . 1992;53:438–444
- Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys . Transplantation . 1995;59:256–262
- . Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys . Transplantation . 1997;64:709–716
- . Transplantation tolerance from a historical perspective . Nat Rev Immunol . 2001;1:233–239
- An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry . Transplantation . 1996;62:1149–1160
- The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients . J Clin Invest . 1997;99:1118–1129
- Evidence for the presence of multilineage chimerism and progenitors of donor dendritic cells in the peripheral blood of bone marrow-augmented organ transplant recipients . Transplantation . 1997;64:735–741
- Continuous observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients . Transplantation . 1998;65:956–965
- . Immunologic tolerance to renal allografts after bone marrow transplants from the same donors . Ann Int Med . 1991;114:954–955
- Combined histocompatibility leucocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism . Transplantation . 1999;68:480–484
PII: S1561-5413(09)60177-0
doi:10.1016/S1561-5413(09)60177-0
© 2005 The Hong Kong Society of Nephrology. Published by Elsevier Inc. All rights reserved.
